InvestorsHub Logo
Followers 1
Posts 86
Boards Moderated 0
Alias Born 12/14/2017

Re: None

Saturday, 10/13/2018 11:56:17 PM

Saturday, October 13, 2018 11:56:17 PM

Post# of 1845
Diegeo overpaid for their last company they bought. They have a market cap 5x that of Constellation. The company only posted a slight growth last year and definitely wants in the cannabis infused market. Vivo is an attractive under the radar target that would be a great deal. Right now Vivo does not have growth output but that will change 10 fold soon.

And don't forget Vivo has two board members that were "shot callers" with Diegeo. I mean Diegeo executives.

My bet is Vivo Cannabis!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.